The new standard of care in hemostasis management
Contents
1. az y Tia e Lu gt gt Lu i l Lu lt are dy Lu Routine coagulation tests are used as a starting place when investigating the cause of bleeding They indicate the time of fibrin formation through the intrinsic and extrinsic pathways of the coagulation cascade While standard tests like PT PTT and platelet count have limited capacity to reveal a patient s risk for bleeding they don t reveal the patient s risk for thrombosis Nor do standard tests provide specific data about clot quality or Thrombosis stability The power of the TEG System is that it reveals the nature of the patient s coagulopathy such as whether the patient is hemorrhagic hypercoagulable or fibrinolytic Effective hemostasis and treatment require that physicians have the most complete information to make medical decisions on how to best maintain a patient s coagulation equilibrium Bleeding The TEGO System helps you keep hemostasis in balance The core of every quality blood management program A new standard of care The TEG 5000 Hemostasis Analyzer System provides a more complete picture of patients hemostasis thus helping you deliver more targeted treatment The TEG System facilitates your understanding of hemorrhagic or thrombotic risk by revealing Rate of clot formation Strength and stability of clot Effect of platelet coagulation factor and cellular interactions Maximum pl2. E Sg RSE er eee BEER RN e For remote network viewing of live or stored data signature graphics interpretation assistance and reporting along with many other features Includes user s manual a ao z E A TA a dic ds Kitis comprised of 6211 2 boxes 6300 1 box 6212 1 box 7003 1 vial 8001 1 box 8002 1 box i e a A BEE Per BR aio la la ARE e nicol el FERNER r PER EN RENTE Order one kit per analyzer Kit is comprised of 8001 1 box 8002 1 box 6211 2 boxes a PE PEE ET a ena Pere NEUERE EEE A standardized reagent that activates the blood sample through the intrinsic pathway for clot activation a i e 7 EEN AA EE AE AE E EET a a enanos T Each vial contains 5 mL of 0 2M calcium chloride solution pa cn O E A ea A reagent that activates and accelerates the clotting process Produces earlier TEG ACT on o a ee E E ee ee a ie road cr Reagent used to measure the functional fibrinogen contribution to clot strength Produces TEG parameter results and estimated fibrinogen level FLEV Oi no a i i ae a ea er a ie ee a a oros dile cableados O ne nn ns a o RA aD T EEEE o pe er ees Reagents to measure platelet inhibition and total platelet function Aids in antiplatelet therapy decisions for arachidonic acid and glycoprotein Ilb Illa receptor inhibitors i a Ea er RESTE RER iii a oia a a sacras Whole blood coagulation control formulated to produce normal results nn a E A E ES ES EE o E E E nn IN a RETTEN PER
3. Whole blood coagulation control formulated to produce abnormal results i ef a ae 2 a o RR EIER Chetan S EN N E E ee e ERSTES AA i eer oe seas Tere to E oca ren a y ir iets AAPP E sbereueeweiesias sauseneet A A e ace nn E E ee oe ns lese MEERE RxOnly Copyright O 2008 2013 Haemonetics Corporation Haemonetics RapidTEG and TEG are trademarks or registered trademarks of Haemonetics Corporation in the USA other countries or both PlateletMapping is a trademark of Cora Healthcare Plavix is a registered trademark of Bristol Myers Squibb Sanofi Pharmaceuticals Partnership 1 2013 USA COL PP 000078 US AH Haemonetics Corporation m 400 Wood Road m Braintree MA 02184 m USA m 800 225 5242 m www haemonetics com
4. Monitor resolution 1024 x 768 or greater 1 6 GHz Pentium 4 processor or higher 1 GB RAM or higher 10 GB hard drive Available COM port RS232 9 pin serial port SVGA video adapter running 24 bit color settings in Windows CD ROM drive for installation recommend CD RW instead for backup and data transfer Network adapter if network access required Windows 2000 Professional SP4 or higher Windows XP Professional SP2 or higher Windows compatible printer if hard copy is required Uninterruptible power supply UPS Optional Touch screen interface requires either additional COM port or USB port Bar code scanner for patient ID and operator ID information requires additional COM port TCP IP connection required if LIS interface is anticipated B TEG remote version e g Laboratory OR ICU CCU ER etc To install and use TEG Analytical Software on a TEG remote version all of the above is needed except for having an available com port and UPS To contact Customer Service Phone 800 537 2802 e Fax 800 860 1512 Email CustomerServiceNA haemonetics com Quantity List per Each Description Number Ordered a n a ee A A eo iras o er ene a cae A en erent ee rae SPERREN a Up to four 4 TEG Analyzers can be attached to a single installation kit Includes analog to digital converter cables software clinical aid booklet laminated decision tree and user s manual a a on ae Sa Me
5. atelet function Risk of hemorrhage and thrombosis and identification of fibrinolysis If a patient has been inhibited too much or too little m Coagulation MA a Platelets The process is simple Small sample of whole blood is collected and placed in the TEG analyzer Torsion wire and pin is suspended in sample Sample cup rotates Clot begins to form and bind the cup and pin Time to clot maximum clot strength and clot breakdown are measured and analyzed Fibrinolysis Clot strength Platelet function Enzymatic Fibrinogen R K Clotting time Clot kinetics Coagulation Factors Thrombolysins Ly30 EPL Clot stability Clot breakdown The TEG System provides visual representation of your patient s hemostasis Added Value Understanding platelet inhibition through the PlateletMapping Assay How do you know if 50 inhibition is good or bad if you don t know the patient s baseline risk Many protocols require patients to come off Plavix and The TEG PlateletMapping Assay measures platelet aspirin prior to surgery in order to minimize the risk of function and tells you the patient s level of inhibition as bleeding But what if you interrupt anti platelet medication it relates to his baseline function providing insight into on a patient who is already predisposed to thrombotic his relative thrombotic or hemorrhagic risk With this events information at han
6. d you can be more confident making treatment decisions Facilitating or inhibiting platelet function before surgery without understanding the patient s baseline function could put your patient at risk for a thrombotic or hemorrhagic event and increase the cost of patient care administering too little could lead to clotting while administering too much could lead to bleeding Patient A s PlateletMapping baseline shows that he was hypercoagulable The results show that even though he has been inhibited 50 he remains hypercoagulable Patient A Patient B Patient C 50 Normal 50 x 5 3 Patient B s PlateletMapping baseline Hypocoagulable i pping Net TEG shows that he was hypercoagulable Total platelet At 50 inhibition he is now within the normal coagulation range Net platelet function Patent C s PlateletMapping baseline shows that he was normal But after 50 t inhibition he is now hypocoagulable The TEG System tells you more than the level of inhibition PlateletMapping Assays can show you the patient s baseline coagulopathy BEFORE inhibition and compares that baseline to his current coagulation state The PlateletMapping Assay enables you to deliver personalized treatment that is based on empirical data specific to that patient Improving patient outcomes Adding the TEG 5000 Hemostasis Analyzer System to Given that a TEG analysis ca
7. n aid the prediction of a your hemostasis management can help improve patient surgical bleed greater than 95 of the time you can more outcomes and may decrease healthcare costs appropriately decide whether to re explore or administer component therapy Patients regularly treated with red blood cells RBCs because of bleeding are then also administered both Hospitals can realize cost savings based simply on the FFP and platelets because the underlying reason for the reduction of unnecessary blood component transfusions bleeding is unknown By simply having a more thorough However since allogeneic transfusions are associated understanding of patients hemostasis unnecessary with greater infection rates greater complication risks and allogeneic transfusions could be avoided longer lengths of stay actual savings may be even more significant 58 Total Cost Reduction after TEG Implementation 70 000 65 865 Before TEG 60 000 E After TEG 50 000 40 000 4 31 498 30 000 4 26 775 27 456 20 000 y 15 750 10 100 10 000 y 4 872 2 720 0 966 119640 Packed Red Fresh Frozen Single Donor Cryoprecipitate Total Cells Plasma Platelets Reduced by Reduced by Reduced by Reduced by Reduced 41 80 68 76 by 58 Transfused Product Cost 30 patients before TEG monitoring vs 30 patients after TEG monitoring Data obtained from a 710 bed hospital in the southwestern U
8. nited States Data on file at Haemonetics COL COPY 000196 1 Johansson PI ISBT Science Series 2007 2 159 167 DR107494 2 Leal Noval et al Chest 2001 119 1461 1468 DR107496 3 Shapiro et al J Trauma 2003 Aug 55 2 269 73 discussion 273 4 DR107495 TEG 5000 Technical Specifications Device Specifications Two 2 independent measuring channels per analyzer up to eight 8 channels per computer Cables included software sold separately Cup drive Line synchronized with synchronous motor Temperature control Individual temperature control for each channel Measuring technique Shear elasticity of a coagulating sample determined by motion of the pin Transducer Electrical mechanical transducer of movement of torsion wire connected to the suspended pin Sample volume 360 uL Power External power supply CSA listed 120V model 60 Hz or 220V model 50 Hz Initial warm up time Less than five 5 minutes to warm sample Operating position Setting verified with spirit level Dimensions 11 4 in x 8 6 in x 7 0 in 29 cm x 22 cm x 18 cm Weight 12 lbs 5 4 kg Computer Hardware Software Requirements Computer required for TEG system operation to be obtained from your IT department or purchasing departments or through another external source To be configured as follows Supported configurations A TEG enabled version e g Laboratory OR ICU CCU ER etc
Download Pdf Manuals
Related Search